|
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The objectives of the study are to present a comprehensive look at the
markets and strategies for U.S. bioterrorism treatments. Markets are divided
into the various types of bioterrorism agents that present a threat to the U.S.
And other nations. The report is a deviation from the normal market reports
presented by BCC, Inc. This report is based largely on what might happen in the
event of a widespread bioterrorism attack on the United States in major
metropolitan areas. The report is directed to decision-makers in the various
biologic, chemical and nuclear segments to present insight into those areas for
current and future development. The report could be especially useful to small
developing biotech firms that want to enter the area of bioterrorism treatments.
The report identifies the areas of bioterrorism treatment that have substantial
competitors and products available but it also targets segments of bioterrorism
where there are emergent needs and it identifies the potential revenues that
could be generated should a bioterrorism attack occur. Each segment is broken
down into the cost per treatment and multiplied by the estimated number of
victims and the number that would need to be treated in a given geographical
area. This formula could be applied to any known population to extrapolate
potential revenues in the event of an outbreak.
REASONS FOR STUDY
This BBC study is presented to heighten the awareness of bioterrorism, to
realize the magnitude of the threat, to explore the likelihood of attack, and to
identify pharmaceutical products currently available and products in development
for bioterrorism. The study analyzes the world of bioterrorists, examining
several bioterrorist organizations and bringing to the forefront, the real
possibility of bioterrorist actions by any one of these groups. It also
addresses the current products available to treat bioterrorism events. The study
covers the consequences of a future event, identifying impact on major
metropolitan areas and the costs involved. Because of the seriousness of this
subject and the real threat that was experienced in 2001, market participants
have responded to the call by the government for assistance and cooperation in
dealing with the bioterrorism threat. The study demonstrates how the government,
academia, pharmaceutical industry participants and the general public are
working together to remain vigilant in this very important area that threatens
the entire world.
SCOPE OF STUDY
The report is designed to be a comprehensive business tool to provide an
in-depth look at bioterrorism and the possible ramifications of a bioterrorist
attack. The geographic scope of the report is the United States. The report
identifies the different areas of bioterrorism; gives a brief explanation of
each area; cites the risk factors; calculates the incidence and mortality; and
sites potential treatments in research and development, potential market size
and market strategies. The report describes the industry in detail, its
relationship to the healthcare industry, its participants, and its trends for
the future.
Within the Markets and Strategies for the U.S. Bioterrorism Treatments,
segments are divided according to type:
- Biological weapons
- Chemical weapons
- Nuclear weapons
All segments are further broken down into specific entities. Each sub-segment
is described in detail. The entire segment is evaluated by identifying current
market size, identifying current and potential market drivers, forecasting for
2001, 2005, and 2015.
METHODOLOGY AND INFORMATION SOURCES
The information and analysis presented in this BCC report are based on
extensive first-hand interviews with primary executives, product managers,
government experts and participating organization executives. Background
information was obtained from various government, business, medical journal and
trade magazines and interviews with disaster personnel. Key information from
published literature was used to conduct interviews with over 50 industry
participants to validate and obtain expert opinions on current and future
trends. All information gathered was used to extrapolate figures for the 2005
and 2015 markets in the event of a bioterrorism attack on major metropolitan
areas. The figures are by no means exact but are derived from analyst
calculations based on all information gathered.
All market data pertain to the U.S. market at the manufacturers' level. Data
are expressed in current U.S. dollars. The base year was 2001; there was no
historical data because prior to 2001, there had been no bioterrorist attack of
this magnitude. Forecast data are provided for 2005 and 2015 based on the
products in development and the populations affected. | 
View Cart
